IL-12 and IL-23 pathway inhibition in inflammatory bowel disease-Reference-Cited by-同舟云学术

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

Published:2023-04-17 Issue:7 Volume:20 Page:433-446
ISSN:1759-5045
Container-title:Nature Reviews Gastroenterology & Hepatology
language:en
Short-container-title:Nat Rev Gastroenterol Hepatol

Author:

Verstockt Bram,Salas Azucena^ORCID,Sands Bruce E.^ORCID,Abraham Clara,Leibovitzh Haim^ORCID,Neurath Markus F.,Vande Casteele Niels^ORCID,Danese Silvio,D’Haens Geert,Eckmann Lars,Faubion William A.,Feagan Brian G.,Jairath Vipul,Ma Christopher,Mehandru Saurabh,Panes Julian,Rieder Florian,Sandborn William J.,Silverberg Mark S.,Veny Marisol,Vermeire Severine,Vetrano Stefania,

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Hepatology

Link

https://www.nature.com/articles/s41575-023-00768-1.pdf

Reference156 articles.

1. Chang, J. T. Pathophysiology of inflammatory bowel diseases. N. Engl. J. Med. 383, 2652–2664 (2020).

2. Baumgart, D. C. & Le Berre, C. Newer biologic and small-molecule therapies for inflammatory bowel disease. N. Engl. J. Med. 385, 1302–1315 (2021).

3. Roda, G., Jharap, B., Neeraj, N. & Colombel, J. F. Loss of response to anti-TNFs: definition, epidemiology, and management. Clin. Transl. Gastroenterol. 7, e135 (2016).

4. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).

5. Verstockt, B., Van Assche, G., Vermeire, S. & Ferrante, M. Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Expert. Opin. Biol. Ther. 17, 31–47 (2017).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging thiol-functionalized biomucoadhesive hybrid nanoliposome for local therapy of ulcerative colitis;Biomaterials;2025-01

2. Case-control study of IL23R rs76418789 polymorphism, smoking, and ulcerative colitis in Japan;Cytokine;2024-11

3. Age and sex-dependent gut alterations in mice induced by neonatal immune activation with lipopolysaccharide;Journal of Neuroimmunology;2024-10

4. Iturin A and Gramicidin A inhibit proliferation, trigger apoptosis, and regulate inflammation in breast cancer cells;Journal of Drug Delivery Science and Technology;2024-10

5. Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study;Clinical Pharmacology in Drug Development;2024-09-04